Drug profile · INN
eptacog alfa (activated)
HEMARYO
eptacog alfa (activated) (HEMARYO) is a coagulation factor vii exogenous protein.
EMA: approved PMDA: approved Blood and blood forming organs (B02) B02BD08
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — eptacog alfa (activated)
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
eptacog alfa (activated) (HEMARYO) is a coagulation factor vii exogenous protein.
Key facts
INN eptacog alfa (activated)
Brand HEMARYO
Mechanism Coagulation factor VII exogenous protein
Target Coagulation factor VII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD08
Mechanism of action
Coagulation factor VII exogenous protein
Primary target: Coagulation factor VII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is eptacog alfa (activated)?
eptacog alfa (activated) (HEMARYO) is a coagulation factor vii exogenous protein.
What is the brand name for eptacog alfa (activated)?
HEMARYO is a marketed brand name for eptacog alfa (activated). Check FDA Drugs@FDA for the current US label holder and prescribing information.